Patent · US Active

Modulation of gene expression in a human bioreactor

US11697834B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Maxwell Biosciences, Inc. · US

Inventors

Annelise E. Barron · Palo Alto, US
David Haase · Fuquay-Varina, US
Joshua P. McClure · Jenison, US

Key dates

Filing date	Jan 27, 2020
Grant date	Jul 11, 2023
Priority date	—
Expiry date	Sep 30, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2560/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is provided for treating a recipient with a biological product obtained from at least one donor that may be the same as, or different from, the recipient. The method includes identifying a targeted level of gene expression of a first gene in a biological product to be transferred from at least one donor to a recipient; treating the at least one donor to achieve the targeted level of gene expression of the first gene in the biological product; and transferring the biological product from the at least one donor to the recipient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.